ArticleCureus2026
Phototherapy-Associated Changes in Ionized Calcium Among Neonates Born at ≥35 Weeks of Gestation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Phototherapy is the standard treatment for clinically significant unconjugated neonatal hyperbilirubinemia. Although generally safe and effective, phototherapy has been associated with alterations in calcium homeostasis. The magnitude and clinical relevance of phototherapy-associated reductions in ionized calcium (iCa) remain uncertain, particularly among neonates born at ≥35 weeks of gestation. Objective To evaluate changes in iCa before and after phototherapy in neonates born at ≥35 weeks with unconjugated hyperbilirubinemia. Methods This prospective cohort study included 145 neonates born at ≥35 weeks who received phototherapy for at least 24 hours for unconjugated hyperbilirubinemia at the Department of Pediatrics, Baba Raghav Das (BRD) Medical College, Gorakhpur, India, from August 2021 to August 2022. Ionized calcium was measured immediately before the initiation of phototherapy and after 24 hours of phototherapy using an ion-selective electrode (ISE) method and was categorized as <1.20, 1.20-1.40, and >1.40 mmol/L. Changes in the paired distribution of iCa categories were assessed using the Stuart-Maxwell test of marginal homogeneity. Results The mean gestational age was 36.93 ± 1.49 weeks; 64 (44.1%) neonates were born before 37 weeks, and 82 (56.6%) were male. Before phototherapy, 12/145 (8.3%) neonates had iCa <1.20 mmol/L, compared with 54/145 (37.2%) after 24 hours of phototherapy, representing an absolute increase of 28.9 percentage points. Among 133 neonates with baseline iCa ≥1.20 mmol/L, 44 (33.1%) developed iCa <1.20 mmol/L after 24 hours of phototherapy. The proportion with iCa >1.40 mmol/L decreased from 109/145 (75.2%) before treatment to 30/145 (20.7%) after 24 hours. The overall shift in paired iCa categories was statistically significant (Stuart-Maxwell χ² = 83.808, df = 2, p < 0.001). Conclusion Phototherapy was associated with a significant downward shift in iCa among neonates born at ≥35 weeks of gestation. Among neonates without low iCa at baseline, 33.1% developed concentrations <1.20 mmol/L after 24 hours of phototherapy. These findings demonstrate an important biochemical association; however, further studies are needed to determine its clinical significance and identify neonates who may benefit from targeted iCa monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.